Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass.

Smoum R, Bar A, Tan B, Milman G, Attar-Namdar M, Ofek O, Stuart JM, Bajayo A, Tam J, Kram V, O'Dell D, Walker MJ, Bradshaw HB, Bab I, Mechoulam R.

Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17710-5. doi: 10.1073/pnas.0912479107. Epub 2010 Sep 27.

2.

CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts.

Ofek O, Attar-Namdar M, Kram V, Dvir-Ginzberg M, Mechoulam R, Zimmer A, Frenkel B, Shohami E, Bab I.

J Bone Miner Res. 2011 Feb;26(2):308-16. doi: 10.1002/jbmr.228.

3.

Endocannabinoids and the regulation of bone metabolism.

Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A.

J Neuroendocrinol. 2008 May;20 Suppl 1:69-74. doi: 10.1111/j.1365-2826.2008.01675.x. Review.

PMID:
18426503
4.

Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling.

Tam J, Ofek O, Fride E, Ledent C, Gabet Y, Müller R, Zimmer A, Mackie K, Mechoulam R, Shohami E, Bab I.

Mol Pharmacol. 2006 Sep;70(3):786-92. Epub 2006 Jun 13.

PMID:
16772520
5.

Peripheral cannabinoid receptor, CB2, regulates bone mass.

Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I.

Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):696-701. Epub 2006 Jan 9.

Supplemental Content

Support Center